Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16LGND144STEPHEN L. SABBA plan to sell securities of LIGAND PHARMACEUTICALS INCORPORATED under Form 144MEDIUM
STEPHEN L. SABBA filed Form 144 to notify SEC of plan to sell 2145 units of LIGAND PHARMACEUTICALS INCORPORATED securities around 2026-06-16, with aggregate market value of $544,830.00. The total outstanding units is 20041061.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-06-16ONC144CHAN LEE plan to sell securities of BeOne Medicines Ltd. under Form 144MEDIUM
CHAN LEE filed Form 144 to notify SEC of plan to sell 590 units of BeOne Medicines Ltd. securities around 2026-06-16, with aggregate market value of $156,925.25. The total outstanding units is 54885669.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mega CapBiotechnology
2026-06-16CORT144MAHONEY DAVID L plan to sell securities of CORCEPT THERAPEUTICS INC under Form 144MEDIUM
MAHONEY DAVID L filed Form 144 to notify SEC of plan to sell 20000 units of CORCEPT THERAPEUTICS INC securities around 2026-06-16, with aggregate market value of $1,666,800.00. The total outstanding units is 107351594.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Mid CapBiotechnology
2026-06-16ANAB144DENNIS MULROY plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
DENNIS MULROY filed Form 144 to notify SEC of plan to sell 1265 units of ANAPTYSBIO, INC. securities around 2026-06-16, with aggregate market value of $75,900.00. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months in...
Small CapBiotechnology
2026-06-16NKTR144ROBIN HOWARD W plan to sell securities of NEKTAR THERAPEUTICS under Form 144MEDIUM
ROBIN HOWARD W filed Form 144 to notify SEC of plan to sell 10000 units of NEKTAR THERAPEUTICS securities around 2026-06-16, with aggregate market value of $609,600.00. The total outstanding units is 33786032.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 mon...
Mid CapBiotechnology